Tom Peyser

Tom Peyser is a medical device consultant with over 25 years of experience in the field. Tom is currently the SVP of Clinical & Regulatory Affairs at Biolinq, a position they have held for 2 years and 10 months. Prior to this, Tom was the Vice President of Science and Technology at Dexcom for 3 years.

Tom’s other notable positions include Vice President of Clinical Affairs at GluMetrics, Inc. for 3 years and 7 months, Director of Technology Assessment at Abbott Diabetes Care for 2 years and 3 months, and Vice President of Technology and Engineering at MedOptix for 1 year and 8 months.

Tom has also been an active member of various boards, including Bionic Sight LLC for 8 years and 2 months. Tom was also a co-founder of Mode AGC (Automated Glucose Control) LLC, where they served as Chief Scientist for 7 years and 10 months. In 2016, Mode AGC entered into a partnership with Insulet (Billerica, MA).

Tom’s areas of expertise include diabetes technology, continuous glucose monitoring (CGM) systems, artificial pancreas systems, and the use of sensors for the treatment and management of various medical conditions. Tom has also been involved in the design of clinical studies and the analysis and interpretation of CGM clinical data.

Tom Peyser earned their Doctor of Philosophy in Physics from the University of Maryland College Park in 1986. Tom earned their Bachelor of Arts in Physics from New York University in 1980 magna cum laude.

The colleagues that work with Tom Peyser include: Jared Tangney, Joshua Windmiller, Andre Gamelin, and Naresh Bhavaraju.